Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11 USD | +1.10% | +0.92% | -20.29% |
Strengths
- The group's high margin levels account for strong profits.
- Its low valuation, with P/E ratio at 5.98 and 5.35 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Corporate Financial Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.29% | 272M | - | ||
+8.60% | 16.07B | C | ||
+12.15% | 14.43B | B- | ||
+6.83% | 9.22B | B+ | ||
-12.95% | 8.32B | A | ||
-0.97% | 6.07B | B- | ||
+66.00% | 5.5B | - | - | |
+2.27% | 4.89B | B- | ||
+62.35% | 4.45B | - | C | |
-6.25% | 4.08B | - | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NEWT Stock
- Ratings NewtekOne, Inc.